Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.02B | 963.64M | 776.95M | 585.94M | 387.86M | 236.58M |
Gross Profit | 752.20M | 706.17M | 547.28M | 383.53M | 250.57M | 161.10M |
EBITDA | -387.39M | -419.15M | -430.01M | -455.05M | -335.99M | -231.61M |
Net Income | -319.67M | -345.06M | -442.75M | -452.55M | -342.80M | -229.83M |
Balance Sheet | ||||||
Total Assets | 2.70B | 2.69B | 2.46B | 2.34B | 2.34B | 526.12M |
Cash, Cash Equivalents and Short-Term Investments | 1.92B | 1.91B | 1.90B | 1.93B | 2.02B | 288.55M |
Total Debt | 1.11B | 1.11B | 1.11B | 1.12B | 1.12B | 50.93M |
Total Liabilities | 1.67B | 1.73B | 1.65B | 1.58B | 1.49B | 832.37M |
Stockholders Equity | 1.03B | 961.23M | 810.41M | 769.48M | 850.28M | -306.25M |
Cash Flow | ||||||
Free Cash Flow | 12.98M | 9.49M | -124.34M | -171.79M | -114.00M | -86.71M |
Operating Cash Flow | 32.66M | 33.46M | -103.66M | -157.33M | -105.06M | -82.06M |
Investing Cash Flow | -170.22M | -74.98M | -84.85M | -865.80M | -400.58M | -176.86M |
Financing Cash Flow | 80.60M | 79.81M | 102.37M | 82.24M | 1.84B | 276.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $8.48B | 5,193.62 | 0.09% | ― | 2.28% | ― | |
77 Outperform | $16.70B | ― | -4.00% | ― | 19.24% | 59.66% | |
68 Neutral | $6.88B | ― | -3.62% | ― | 7.21% | 23.13% | |
64 Neutral | $8.71B | ― | -34.18% | ― | 24.11% | 21.87% | |
64 Neutral | $7.76B | 18.10 | -60.11% | ― | 0.79% | 0.59% | |
64 Neutral | $6.03B | ― | -26.98% | ― | 32.25% | 20.56% | |
59 Neutral | €3.24B | 12.45 | -9.91% | 2.76% | 2.38% | -49.53% |
On June 11, 2025, Confluent, Inc. conducted its 2025 Annual Meeting of Stockholders, where holders of Class A and Class B common stock participated in voting on three proposals. The stockholders elected Class I directors to serve until 2028, ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025, and approved the compensation of named executive officers on a non-binding advisory basis.
The most recent analyst rating on (CFLT) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on Confluent stock, see the CFLT Stock Forecast page.